Dr. Pieter Cullis
Director, Life Sciences Institute, University of British Columbia
Pieter R. Cullis, Ph.D. FRSC, Director, Life Sciences Institute, University of British Columbia; Director, NanoMedicines Research Group; Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology. Dr. Cullis and co-workers have been responsible for fundamental advances in the design and application of “smart” nanomedicines for personalized therapies, including gene therapies. This work has contributed to three drugs that have been approved by regulatory agencies in the U.S. and Europe for the treatment of cancer and its complications. Dr. Cullis has co-founded ten biotechnology companies, has published over 300 scientific articles and is an inventor on over 60 patents. He also co-founded the Centre for Drug Research and Development (CDRD) in 2004 and the Personalized Medicine Initiative (PMI) in 2012. The PMI has 10 projects underway to implement molecularly-based personalized medicine into clinical practice in BC. Dr. Cullis has received many awards and was elected a Fellow of the Royal Society of Canada in 2004. He was also awarded the Prix Galien, Canada’s premier prize for achievements in pharmaceutical R&D, in 2011. In 2015 Dr. Cullis published “The Personalized Medicine Revolution: How Diagnosing and Treating Disease are About to Change Forever”, see http://www.amazon.com/The-Personalized-Medicine-Revolution-Diagnosing/dp/1771640383.
Pieter R. Cullis, Ph.D. FRSC, Director, Life Sciences Institute, University of British Columbia; Director, NanoMedicines Research Group; Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology. Dr. Cullis and co-workers have been responsible for fundamental advances in the design and application of “smart” nanomedicines for personalized therapies, including gene therapies. This work has contributed to three drugs that have been approved by regulatory agencies in the U.S. and Europe for the treatment of cancer and its complications. Dr. Cullis has co-founded ten biotechnology companies, has published over 300 scientific articles and is an inventor on over 60 patents. He also co-founded the Centre for Drug Research and Development (CDRD) in 2004 and the Personalized Medicine Initiative (PMI) in 2012. The PMI has 10 projects underway to implement molecularly-based personalized medicine into clinical practice in BC. Dr. Cullis has received many awards and was elected a Fellow of the Royal Society of Canada in 2004. He was also awarded the Prix Galien, Canada’s premier prize for achievements in pharmaceutical R&D, in 2011. In 2015 Dr. Cullis published “The Personalized Medicine Revolution: How Diagnosing and Treating Disease are About to Change Forever”, see http://www.amazon.com/The-Personalized-Medicine-Revolution-Diagnosing/dp/1771640383.
